Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zenith Epigenetics Corp.
DescriptionSmall molecule inhibitor of BET bromodomain proteins, including bromodomain containing 4 (BRD4)
Molecular Target Bromodomain containing 4 (BRD4) ; BET bromodomain proteins
Mechanism of ActionBromodomain containing 4 (BRD4) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationProstate cancer
Indication DetailsTreat metastatic castration-resistant prostate cancer (CRPC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today